These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9090301)
21. [Elevation of 7-dehydrocholesterol concentrations in serum and liver and pericentral peroxisome proliferation in hepatocytes of rats after inhibition of cholesterol biosynthesis by BM 15,766]. Weiss MC; Baumgart E; Fahimi HD; Pill H; Rebel W; Hartig F Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):66-9. PubMed ID: 7786281 [TBL] [Abstract][Full Text] [Related]
22. Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins. Herrero-Martin G; López-Rivas A FEBS Lett; 2008 Jul; 582(17):2589-94. PubMed ID: 18582466 [TBL] [Abstract][Full Text] [Related]
23. Actin' up: RhoB in cancer and apoptosis. Prendergast GC Nat Rev Cancer; 2001 Nov; 1(2):162-8. PubMed ID: 11905808 [TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of statins. Gurwitz D Lancet; 1996 Dec; 348(9041):1583. PubMed ID: 8950894 [No Abstract] [Full Text] [Related]
25. [Abnormal metabolism of lipids and proteins in neoplastic cell division]. Kojima K Nihon Rinsho; 1986 Feb; 44(2):345-52. PubMed ID: 3517414 [No Abstract] [Full Text] [Related]
26. Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells. Stayrook KR; McKinzie JH; Barbhaiya LH; Crowell PL Anticancer Res; 1998; 18(2A):823-8. PubMed ID: 9615726 [TBL] [Abstract][Full Text] [Related]
27. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist. Egozi Y; Weisz B; Gana-Weisz M; Ben-Baruch G; Kloog Y Int J Cancer; 1999 Mar; 80(6):911-8. PubMed ID: 10074926 [TBL] [Abstract][Full Text] [Related]
28. Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man. Sodhi HS; Kudchodkar BJ; Horlick L; Weder CH Metabolism; 1971 Apr; 20(4):348-59. PubMed ID: 5550302 [No Abstract] [Full Text] [Related]
29. Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design. Lerner EC; Hamilton AD; Sebti SM Anticancer Drug Des; 1997 Jun; 12(4):229-38. PubMed ID: 9199657 [TBL] [Abstract][Full Text] [Related]
36. Protein farnesyltransferase inhibitors. Ayral-Kaloustian S; Salaski EJ Curr Med Chem; 2002 May; 9(10):1003-32. PubMed ID: 12733981 [TBL] [Abstract][Full Text] [Related]
37. Membrane association and targeting of prenylated Ras-like GTPases. Seabra MC Cell Signal; 1998 Mar; 10(3):167-72. PubMed ID: 9607139 [TBL] [Abstract][Full Text] [Related]
38. Drug treats two sources of cholesterol. Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829 [No Abstract] [Full Text] [Related]
39. The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents. Ohkanda J; Blaskovich MA; Sebti SM; Hamilton AD Prog Cell Cycle Res; 2003; 5():211-7. PubMed ID: 14593715 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines. Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]